数据挖掘_AIDS Clinical Trials Group Study 320 Data(艾滋病临床实验小组研究320数据).pdfVIP

AIDS Clinical Trials Group Study 320 Data(艾滋病临 床实验小组研究320 数据) 数据摘要： The data come from a double-blind, placebo-controlled trial that compared the three-drug regimen of indinavir (IDV), open label zidovudine (ZDV) or stavudine (d4T) and lamivudine (3TC) with the two-drug regimen of zidovudine or stavudine and lamivudine in HIV-infected patients (Hammer et al., 1997). Patients were eligible for the trial if they had no more than 200 CD4 cells per cubic millimeter and at least three months of prior zidovudine therapy. Randomization was stratified by CD4 cell c